The capacity of the cytokines gamma interferon (IFN-'y), interleukin-4 (IL-4), and tumor necrosis factor (TNF) to activate tuberculostatic functions in murine bone marrow-derived macrophages (BMMo) was investigated. In confirmation of earlier findings, IFN--y rendered BMM+ capable of inhibiting subsequent infection with Mycobacterium bovis. In contrast, IL-4 and TNF failed to inhibit mycobacterial growth.
Mononuclear phagocytes represent the major habitat of the etiologic agents of tuberculosis, Mycobacterium tuberculosis and Mycobacterium bovis. According to current concepts, acquired resistance against tuberculosis primarily depends on macrophage activation by cytokines from specific T lymphocytes (2) , and it is assumed that gamma interferon (IFN-y) is of particular relevance (10) . However, cytokines other than IFN--y have recently been shown to activate certain macrophage functions (1, 3, 9, 11). We compared the roles of interleukin-4 (IL-4), tumor necrosis factor (TNF), and IFN--y in the activation of tuberculostasis in murine bone marrow-derived macrophages (BMM4O).
In all experiments, serum-free and antibiotic-free media were used for cultivation as well as stimulation and infection of the cells. Bone marrow cells were prepared from the femora of 6-to 8-week-old C57BL/6 male or female mice which were bred under specific-pathogen-free conditions. BMMX were obtained in Teflon film bags (Heraeus, Hanau, Federal Republic of Germany) and harvested after 9 to 10 days of culture as described previously (6, 7 As shown previously, BMM4 stimulated with rIFN--y for 24 h and subsequently infected with M. bovis organisms for 4 to 5 days were able to markedly inhibit intracellular growth of mycobacteria (7) . Under these conditions, namely, activation of BMM4 and subsequent infection with mycobacteria, rIL-4 and rTNF failed to stimulate antimycobacterial activities in BMM4 (Table 1) . On the other hand, in BMM4.
which had first been infected with M. bovis and were afterward stimulated with cytokines for 40 h, rIL-4 induced inhibition of mycobacterial growth (Table 2 ). rIFN-y was capable of activating already infected BMM4, although its activity was reduced when compared with activation of uninfected BMMX (Tables 1 and 2 ) (9). rTNF induced negligible tuberculostasis in infected BMM4. The data presented show that rIL-4 can activate tuberculostatic functions in macrophages already infected with mycobacteria, whereas rIFN--y preferentially acts on noninfected macrophages.
rTNF which alone was totally ineffective showed marked synergy with rIFN--y in the activation of tuberculostasis in BMM4o which were infected afterward. Under these conditions, minute doses of TNF and IFN--y were sufficient for significant inhibition of mycobacterial growth (Table 3) .
In a previous study, we showed that IFN-y activates tuberculostasis in BMMX which are subsequently infected with tubercle bacilli (7) . In humans the situation might be far more complex, since IFN--y has been shown to stimulate mycobacterial growth in human monocytes, while 1,25-dihydroxyvitamin D3 seems to inhibit mycobacterial growth (8) . Taken together, these findings show that in vitro several cytokines contribute to antimycobacterial resistance. Further work will be required to determine whether these observations indeed reflect the in vivo situation.
